These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 23610453

  • 21. Renal sympathetic denervation in hypertension.
    Doumas M, Faselis C, Papademetriou V.
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [Abstract] [Full Text] [Related]

  • 22. Renal denervation: transition from pathophysiology to clinical practice.
    Gossios TD, Ziakas A, Doumas M, Katsiki N, Petroglou D, Kouparanis A, Lillis L, Karvounis H.
    Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
    [Abstract] [Full Text] [Related]

  • 23. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
    Briasoulis A, Bakris G.
    Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
    [Abstract] [Full Text] [Related]

  • 24. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 25. Renal denervation: unde venis et quo vadis?
    Nähle CP, Düsing R, Schild H.
    Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
    [Abstract] [Full Text] [Related]

  • 26. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
    Baker NC, Waksman R.
    Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
    [No Abstract] [Full Text] [Related]

  • 27. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS.
    Clin Exp Hypertens; 2014 Mar; 36(8):525-30. PubMed ID: 24678737
    [Abstract] [Full Text] [Related]

  • 28. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
    Ezzahti M, Moelker A, Friesema EC, van der Linde NA, Krestin GP, van den Meiracker AH.
    J Hypertens; 2014 Jan; 32(1):135-41. PubMed ID: 24131897
    [Abstract] [Full Text] [Related]

  • 29. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 30. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J, Táborský M, Richter D.
    Clin Exp Hypertens; 2013 Jan; 35(3):192-4. PubMed ID: 22891761
    [Abstract] [Full Text] [Related]

  • 31. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 32. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial.
    Ormiston JA, Watson T, van Pelt N, Stewart R, Stewart JT, White JM, Doughty RN, Stewart F, Macdonald R, Webster MW.
    EuroIntervention; 2013 May 20; 9(1):70-4. PubMed ID: 23685297
    [Abstract] [Full Text] [Related]

  • 33. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand.
    Wongpraparut N, Tresukosol D, Roubsantisuk W, Buranakitjaroen P, Chotivoraniyakul C, Pongakasira R.
    J Med Assoc Thai; 2014 Mar 20; 97 Suppl 3():S155-61. PubMed ID: 24772593
    [Abstract] [Full Text] [Related]

  • 34. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y, Persu A, Staessen JA.
    Curr Opin Nephrol Hypertens; 2013 Sep 20; 22(5):511-8. PubMed ID: 23892701
    [Abstract] [Full Text] [Related]

  • 35. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M.
    EuroIntervention; 2013 May 20; 9 Suppl R():R117-21. PubMed ID: 23732142
    [Abstract] [Full Text] [Related]

  • 36. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension.
    Azizi M, Steichen O, Frank M, Bobrie G, Plouin PF, Sapoval M.
    Eur J Vasc Endovasc Surg; 2012 Mar 20; 43(3):293-9. PubMed ID: 22237510
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S, Froeschl M, Ruzicka M.
    Curr Opin Cardiol; 2014 Jul 20; 29(4):336-43. PubMed ID: 24859619
    [Abstract] [Full Text] [Related]

  • 39. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D, Figulla HR, Surber R.
    Expert Rev Med Devices; 2013 Mar 20; 10(2):247-56. PubMed ID: 23480093
    [Abstract] [Full Text] [Related]

  • 40. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 20; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.